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![A 15-day-old infant presented with hyperinsulinemic hypoglycemia suffering from hypotonia, apnea and poor feeding. On physical examination, the abdomen was distended. The laboratory investigations revealed hypoglycemia (12 mg/dL, normal range: 70-110 mg/dL) and hyperinsulinemia with serum insulin levels of 55 IU/mL (normal range: 2,42-13 IU/mL). The baby was administered intravenous glucose infusion up to 20 mg/kg/min and oral feeding was supported with glucose to maintain euglycemic state. After intravenous diazoxide (15 mg/kg/day) and octreotide therapy (30- 45 mcg/kg/day), no sufficient response could be obtained. Axial (A) and coronal (B) T2-weighted magnetic resonance images demonstrated diffuse enlargement of the pancreas with normal parenchymal signal without any focal lesion. Ga-68 DOTATATE positron emission tomography/computed tomography (PET/CT) imaging \[maximum intensity projection anterior (C), axial CT (D), fused PET/CT (E), coronal CT (F) and fused PET/CT (G)\] showed diffusely increased tracer uptake (SUV~max~: 4,84; 3,99 and 3,99 for head, corpus and tail of the pancreas, respectively) in the entire enlarged pancreas (arrows) (with physiological radiotracer distribution throughout the rest of the body) suggesting a diffuse variant of nesidioblastosis. Due to the persistent hyperinsulinemic hypoglycemia and considering the findings in the Ga-68 DOTATATE PET/CT somatostatin receptor imaging, the patient underwent near total pancreatectomy. Histopathologic findings confirmed the diagnosis of diffuse nesidioblastosis, demonstrating diffuse enlargement of pancreatic lobules composed of solid endocrine cell clusters without a tumor. The disarray of lobular architecture with diffuse and irregular hyperplasia of endocrine cells (H: H&E, x100), the continuity between the duct epithelium and endocrine cells (the ductulo-insular complex, arrow) (I: H&E, x200) and immunohistochemistry with chromogranin A staining endocrine cells (J: x200) are demonstrated. Congenital hyperinsulinism is the most common cause of persistent hypoglycemia in infancy, existing in two forms of either focal or a diffuse adenomatous hyperplasia of insulin secretion in the pancreas. The pre-operative differentiation of these two conditions is crucial for disease management ([@ref1],[@ref2]). Focal type can be treated by selective surgical resection in contrast to the diffuse form which requires near total pancreatectomy when resistant to medical treatment ([@ref3]). No clinical or biological features are typical in determining disease type in affected infants. The current methods used for pre-operative differentiation are invasive techniques and do not always provide differential diagnosis ([@ref4],[@ref5],[@ref6]). The definite role of imaging modalities to differentiate diffuse versus focal form has not yet been proven. F-18-fluoro-dihydroxyphenylalanine PET scan has been used in case of hyperinsulinemia with a reported accuracy of 96% in diagnosing focal or diffuse disease, and of 100% in localizing the focal lesion ([@ref3],[@ref7]). To the best of our knowledge, only few case reports have been published regarding the role of somatostatin receptor imaging to distinguish focal disease from diffuse involvement, where Ga-68 DOTATATE PET scan had been applied successfully in one case and Ga-68 DOTATOC PET scan has been reported to have limited success in another report ([@ref1],[@ref8]). The presented case is evident with an enlarged pancreas showing diffuse increased Ga-68 DOTATATE uptake and indicates somatostatin receptor imaging as a valuable option to guide the type of pancreatectomy in patients with persistent hyperinsulinemic hypoglycemia](MIRT-28-83-g1){#f1}
